• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物涂层球囊治疗支架内再狭窄后出现ST段抬高型心肌梗死的晚期血管闭塞病例报告。

A case report of late vessel occlusion presenting as ST-segment elevation myocardial infarction after drug-coating balloon treatment of in-stent restenosis.

作者信息

Marschall Alexander, Del Val David, Bastante Teresa, Rivero Fernando, Alfonso Fernando

机构信息

Department of Cardiology, Servicio de Cardiología, Hospital Universitario de la Princesa, IIS-IP, Universidad Autónoma de Madrid, Calle Diego de Leon 62, Madrid 28006, Spain.

出版信息

Eur Heart J Case Rep. 2024 Nov 25;8(12):ytae619. doi: 10.1093/ehjcr/ytae619. eCollection 2024 Dec.

DOI:10.1093/ehjcr/ytae619
PMID:39659455
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11630520/
Abstract

BACKGROUND

Drug-coated balloons (DCBs) offer an appealing therapeutic alternative for the treatment of patients with coronary in-stent restenosis (ISR). In-segment late lumen loss, translating into recurrent ISR and the clinical need for target lesion revascularization, represents a well-established and thoroughly investigated limitation of DCB in this setting. However, abrupt vessel occlusion, clinically presenting as ST-segment elevation myocardial infarction (STEMI), has not been previously described after DCB therapy for ISR.

CASE SUMMARY

We herein present the case of a 70-year-old patient that underwent percutaneous coronary intervention (PCI) with DCB for ISR. Despite achieving an excellent acute angiographic result (with no flow-limiting dissection and minimal angiographic residual stenosis), the patient presented 3 months later with STEMI due to occlusion of the previously treated segment. After adequate lesion preparation, a drug-eluting stent was implanted with optimal final angiographic result. The patient was discharged 2 days after the PCI without any post-procedural complications and remained asymptomatic at 6-month clinical follow-up.

DISCUSSION

This case report is the first description of an abrupt vessel occlusion presenting as STEMI following a DCB angioplasty for ISR. This exceptional presentation does not dismount the solid evidence supporting the long-term safety of DCB in these challenging patients.

摘要

背景

药物涂层球囊(DCB)为冠状动脉支架内再狭窄(ISR)患者的治疗提供了一种有吸引力的治疗选择。节段内晚期管腔丢失会导致复发性ISR以及对靶病变血运重建的临床需求,这是DCB在这种情况下已被充分证实且深入研究的局限性。然而,DCB治疗ISR后出现的突然血管闭塞,临床上表现为ST段抬高型心肌梗死(STEMI),此前尚未见报道。

病例摘要

我们在此报告一例70岁患者,因ISR接受了DCB经皮冠状动脉介入治疗(PCI)。尽管急性血管造影结果极佳(无血流限制性夹层且血管造影残余狭窄极小),但患者在3个月后因先前治疗节段闭塞出现STEMI。在进行充分的病变预处理后,植入了药物洗脱支架,最终血管造影结果理想。患者在PCI术后2天出院,无任何术后并发症,在6个月的临床随访中无症状。

讨论

本病例报告首次描述了DCB血管成形术治疗ISR后出现的以STEMI表现的突然血管闭塞。这种特殊表现并未削弱支持DCB在这些具有挑战性患者中长期安全性的确凿证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1ae/11630520/1b7c79142880/ytae619f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1ae/11630520/ed5bf0e95333/ytae619il2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1ae/11630520/642af1165744/ytae619f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1ae/11630520/939a64da4de9/ytae619f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1ae/11630520/1b7c79142880/ytae619f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1ae/11630520/ed5bf0e95333/ytae619il2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1ae/11630520/642af1165744/ytae619f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1ae/11630520/939a64da4de9/ytae619f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1ae/11630520/1b7c79142880/ytae619f3.jpg

相似文献

1
A case report of late vessel occlusion presenting as ST-segment elevation myocardial infarction after drug-coating balloon treatment of in-stent restenosis.药物涂层球囊治疗支架内再狭窄后出现ST段抬高型心肌梗死的晚期血管闭塞病例报告。
Eur Heart J Case Rep. 2024 Nov 25;8(12):ytae619. doi: 10.1093/ehjcr/ytae619. eCollection 2024 Dec.
2
Angiography and Optical Coherence Tomography Assessment of the Drug-Coated Balloon ESSENTIAL for the Treatment of In-Stent Restenosis.血管造影和光学相干断层扫描对药物涂层球囊治疗支架内再狭窄的评估至关重要。
Cardiovasc Revasc Med. 2020 Apr;21(4):508-513. doi: 10.1016/j.carrev.2019.07.021. Epub 2019 Jul 23.
3
Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent in Acute Myocardial Infarction: The REVELATION Randomized Trial.紫杉醇涂层球囊血管成形术与药物洗脱支架治疗急性心肌梗死的比较:REVELATION 随机试验。
JACC Cardiovasc Interv. 2019 Sep 9;12(17):1691-1699. doi: 10.1016/j.jcin.2019.04.016. Epub 2019 May 21.
4
[Efficacy comparison of primary percutaneous coronary intervention by drug-coated balloon angioplasty or drug-eluting stenting in acute myocardial infarction patients with de novo coronary lesions].药物涂层球囊血管成形术或药物洗脱支架置入术对急性心肌梗死合并初发冠状动脉病变患者进行直接经皮冠状动脉介入治疗的疗效比较
Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Jul 24;48(7):600-607. doi: 10.3760/cma.j.cn112148-20200327-00254.
5
REVascularization with paclitaxEL-coated balloon angioplasty versus drug-eluting stenting in acute myocardial infarcTION-A randomized controlled trial: Rationale and design of the REVELATION trial.紫杉醇涂层球囊血管成形术与药物洗脱支架在急性心肌梗死中的血管重建比较——一项随机对照试验:REVELATION试验的原理与设计
Catheter Cardiovasc Interv. 2016 Jun;87(7):1213-21. doi: 10.1002/ccd.26241. Epub 2015 Sep 15.
6
Comparison of 2 Different Paclitaxel-Coated Balloons in Coronary In-Stent Restenosis: A Randomized Controlled Trial.两种不同紫杉醇涂层球囊治疗冠状动脉支架内再狭窄的比较:一项随机对照试验
JACC Asia. 2022 Mar 1;2(2):170-179. doi: 10.1016/j.jacasi.2021.11.015. eCollection 2022 Apr.
7
Culprit-Lesion Drug-Coated-Balloon Percutaneous Coronary Intervention in Patients Presenting with ST-Elevation Myocardial Infarction (STEMI).ST段抬高型心肌梗死(STEMI)患者罪犯病变药物涂层球囊经皮冠状动脉介入治疗
J Clin Med. 2025 Jan 28;14(3):869. doi: 10.3390/jcm14030869.
8
Efficacy of drug-coated balloon angioplasty in early versus late occurring drug-eluting stent restenosis: A pooled analysis from the randomized ISAR DESIRE 3 and DESIRE 4 trials.药物涂层球囊血管成形术治疗早期和晚期药物洗脱支架再狭窄的疗效:来自随机 ISAR DESIRE 3 和 DESIRE 4 试验的汇总分析。
Catheter Cardiovasc Interv. 2020 Nov;96(5):1008-1015. doi: 10.1002/ccd.28638. Epub 2019 Dec 2.
9
Neointimal Modification With Scoring Balloon and Efficacy of Drug-Coated Balloon Therapy in Patients With Restenosis in Drug-Eluting Coronary Stents: A Randomized Controlled Trial.药物洗脱支架内再狭窄患者应用切割球囊及药物涂层球囊治疗的新生内膜改变:一项随机对照试验
JACC Cardiovasc Interv. 2017 Jul 10;10(13):1332-1340. doi: 10.1016/j.jcin.2017.04.024.
10
A comparison between drug-eluting stent implantation and drug-coated balloon angioplasty in patients with left main bifurcation in-stent restenotic lesions.药物洗脱支架植入术与药物涂层球囊血管成形术治疗左主干分叉支架内再狭窄病变的对比研究。
BMC Cardiovasc Disord. 2020 Feb 18;20(1):83. doi: 10.1186/s12872-020-01381-9.

本文引用的文献

1
2023 ESC Guidelines for the management of acute coronary syndromes.2023年欧洲心脏病学会急性冠状动脉综合征管理指南。
Eur Heart J. 2023 Oct 12;44(38):3720-3826. doi: 10.1093/eurheartj/ehad191.
2
Clinical burden and implications of coronary interventions for in-stent restenosis.冠状动脉介入治疗支架内再狭窄的临床负担及影响
EuroIntervention. 2021 Aug 6;17(5):e355-e357. doi: 10.4244/EIJV17I5A60.
3
Trends and Outcomes of Restenosis After Coronary Stent Implantation in the United States.美国冠状动脉支架植入术后再狭窄的趋势和结果。
J Am Coll Cardiol. 2020 Sep 29;76(13):1521-1531. doi: 10.1016/j.jacc.2020.08.002.
4
Drug-Coated Balloons for Coronary Artery Disease: Third Report of the International DCB Consensus Group.药物涂层球囊治疗冠状动脉疾病:国际 DCB 共识专家组第三次报告。
JACC Cardiovasc Interv. 2020 Jun 22;13(12):1391-1402. doi: 10.1016/j.jcin.2020.02.043. Epub 2020 May 27.
5
Paclitaxel-coated balloon angioplasty vs. drug-eluting stenting for the treatment of coronary in-stent restenosis: a comprehensive, collaborative, individual patient data meta-analysis of 10 randomized clinical trials (DAEDALUS study).紫杉醇涂层球囊血管成形术与药物洗脱支架治疗冠状动脉支架内再狭窄的比较:10项随机临床试验的综合、协作、个体患者数据荟萃分析(代达罗斯研究)
Eur Heart J. 2020 Oct 7;41(38):3715-3728. doi: 10.1093/eurheartj/ehz594.
6
Stent Thrombosis.支架血栓形成。
Semin Thromb Hemost. 2018 Feb;44(1):46-51. doi: 10.1055/s-0037-1606178. Epub 2017 Oct 9.
7
Percutaneous coronary interventional strategies for treatment of in-stent restenosis: a network meta-analysis.经皮冠状动脉介入治疗策略治疗支架内再狭窄:网状荟萃分析。
Lancet. 2015 Aug 15;386(9994):655-64. doi: 10.1016/S0140-6736(15)60657-2.
8
A Prospective Randomized Trial of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis of Drug-Eluting Stents: The RIBS IV Randomized Clinical Trial.药物洗脱球囊与依维莫司洗脱支架治疗药物洗脱支架内再狭窄的前瞻性随机临床试验:RIBS IV 随机临床试验。
J Am Coll Cardiol. 2015 Jul 7;66(1):23-33. doi: 10.1016/j.jacc.2015.04.063.
9
Drug-coated balloon therapy in coronary and peripheral artery disease.药物涂层球囊在冠状动脉和外周动脉疾病中的应用。
Nat Rev Cardiol. 2014 Jan;11(1):13-23. doi: 10.1038/nrcardio.2013.165. Epub 2013 Nov 5.
10
A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study.紫杉醇涂层球囊血管成形术与普通球囊血管成形术治疗药物洗脱支架再狭窄的随机、多中心、单盲临床试验:PEPCAD-DES 研究。
J Am Coll Cardiol. 2012 Apr 10;59(15):1377-82. doi: 10.1016/j.jacc.2012.01.015. Epub 2012 Feb 29.